Research use only

In stock · depth page

Tesamorelin — recent literature (RUO)

GHRH(1–44) analogue · TH9507

Tesamorelin 10 mg · literature note

For laboratory research use only. Not for human or veterinary use, consumption, compounding into a medicine, or injection. Not authorized by Health Canada. Literature on this page is scientific context only. This page is not a licensed drug, a wellness protocol, or a dosing guide. This research material is not a licensed tesamorelin product.

Recent indexed work often sits in HIV-associated metabolic and neurocognitive research settings. On this site those papers identify the published compound and its endpoint vocabulary. They are not patient-care guidance.

Reading clinical-development papers as a research buyer

Use the papers for compound identity and for the endpoint words the literature actually measured. Do not convert them into self-administration guidance. Do not turn them into wellness or body-composition marketing.

Russo et al. (2024) and Ellis et al. (2025) are the verified recent rows. Falutz et al. (2007) remains the locked core.

Identity

Form

Lyophilized powder, sealed vial

Strength

10 mg lyophilized vial

Purity

≥99% HPLC (see the lot COA)

CAS

  • Tesamorelin: 218949-48-5

PubMed

Selected literature

  • PMID 18057338 (2007) Falutz et al., NEJM — GHRH-analogue metabolic research context (literature only)

Recent literature (2023–2026)

  • PMID 38905488 (2024) Russo et al., AIDS — tesamorelin research context in people with HIV on integrase inhibitors (literature only)
  • PMID 39813152 (2025) Ellis et al., Journal of Infectious Diseases — tesamorelin and neurocognitive endpoints in persons with HIV (literature only)

Literature is scientific context only. A paper does not make a research vial into a licensed medicine.

Bench reconstitution

Reconstitute from the parent brief when the 10 mg vial is in hand. This page is the literature set.

Diluent page: bacteriostatic water.

Storage

Keep the lyophilized vial at 2–8 °C, protected from light and moisture, until the bench protocol calls for it. After reconstitution, hold at 2–8 °C; use within the sterility window your laboratory controls allow. Do not freeze–thaw repeatedly. Record open date and concentration in the notebook. Confirm the lot COA before you adopt a hold time.

Certificate of analysis

Every product has a View COA button. Where the lot certificate of analysis (identity and HPLC purity) is posted, it opens the certificate with a PDF download. Where it is not posted yet, the same button sends a request by email to request@pharmapeptidesrx.com, or you can write that address with the SKU. This page is not a COA.

Lab FAQ

Can these papers be cited as proof of human use for the catalog vial?

No. The catalog material remains research use only. The papers are literature context. Write request@pharmapeptidesrx.com. This page does not publish prices or banking details. Invoices go out from request@ only.

In this library

In stock · list price

Request from the catalog

Every vial on the catalog shows its CAD list price. Add it to your request and we email the invoice. Labs pay by Interac e-Transfer. No card checkout.